NCT00699725

Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients

Compliance of Gastroprotection Treatment in the Prevention of Gastrointestinal Risk in Non-Steroidal Anti-inflammatory Drug (NSAID) Using Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Prospective multicentric study to evaluate the compliance of gastroprotective treatment in NSAID patients at risk of GI complications. Secondary objectives: To identify the factors associated to treatment compliance (both NSAID and PPI), to evaluate the relationship between compliance and NSAID-associated GI events

Conditions

• Compliance
• Gastroprotector Therapy
• Risk Factors

Timeline

• Start date: 2008-05-01
• Primary completion: 2009-01-01
• Completion: 2009-01-01
• First posted: 2008-06-18
• Last updated: 2010-12-07

Locations

128 sites across 1 country: Spain